Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Sarcoma Channel is supported with funding from Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ASCO 2021 | Hot topics in sarcoma at ASCO 2021

Brian Van Tine, MD, PhD, Washington University School of Medicine in St.Louis, St Louis, MO, discusses key updates in the treatment and management of patients with sarcoma from the American Society of Clinical Oncology (ASCO) 2021 meeting, including the updates from the SPEARHEAD study (NCT04044768) in synovial sarcoma, updates in the use of PARP inhibitors, and biomarkers of response. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

Disclosures

Prof Van Tine, MD, PhD, has an advisory board role at Polaris and Adaptimmune.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.